Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Croda International ( (GB:CRDA) ) just unveiled an update.
Croda International has disclosed a routine share-based transaction involving Executive Committee member Thiruselvan Jayalakshmi Maruthapillai, in line with regulatory requirements for persons discharging managerial responsibilities. The executive exercised a conditional award of 60 ordinary shares under the company’s 2014 Performance Share Plan, a nil-cost transaction executed on 17 March 2026 on the London Stock Exchange, reflecting ongoing use of equity incentives to align management and shareholder interests.
The small size and nil consideration of the award indicate no material impact on Croda’s capital structure or immediate financial position. However, such disclosures provide transparency around executive remuneration practices and help investors monitor how performance-related share plans are implemented at the specialty chemicals group.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2917.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International Plc is a specialty chemicals company that develops and supplies high-performance ingredients and technologies to sectors such as consumer care, life sciences and industrial markets. The group focuses on innovative, sustainable solutions used in products ranging from personal care and pharmaceuticals to crop protection and advanced materials.
Average Trading Volume: 560,821
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.7B
Find detailed analytics on CRDA stock on TipRanks’ Stock Analysis page.